Is compounded tirzepatide the same drug as Zepbound?

It contains the same active ingredient, but it is a different product: made by a pharmacy rather than the manufacturer, not reviewed by FDA, sometimes with a different salt form, concentration or added ingredients, and without the trial evidence that supports the approved product.

Why is compounded medication cheaper?

Compounding pharmacies buy the active ingredient and prepare vials without the approved product's development, trial and marketing costs, and without the manufacturer's list price. The lower price comes with the absence of FDA review of the finished product.

Published August 27, 2026 · updated August 27, 2026 · medically reviewed by Dr. S. Shuwart, MD on August 27, 2026

Medically reviewed · August 27, 2026

Brand-name vs compounded GLP-1: what the difference is and what it costs

Zepbound, Mounjaro, Wegovy and Ozempic are FDA-approved products with trial evidence; compounded semaglutide and tirzepatide are pharmacy-made preparations that are not. The differences in regulation, evidence, formulation and price, with verified figures where we have them.

What “brand-name” means

Zepbound and Mounjaro (tirzepatide) and Wegovy and Ozempic (semaglutide) are products approved by the FDA after phase 3 trials. Approval covers a specific formulation, strength, device and manufacturing process, and the label states the indications, the dosing schedule, the warnings and the trial results. Every dose that leaves the factory is made under the manufacturer’s quality system and inspected by FDA.

What “compounded” means

A compounded GLP-1 is prepared by a pharmacy from the active pharmaceutical ingredient. Two kinds of pharmacy compound:

503A pharmacies compound for an individual patient on a prescription, under state board of pharmacy oversight and USP standards. They are not required to register with FDA or to follow current good manufacturing practice.
503B outsourcing facilities register with FDA, follow current good manufacturing practice, are inspected by FDA and may compound in bulk without patient-specific prescriptions under certain conditions.

Neither produces an FDA-approved product. FDA does not review compounded preparations for safety, effectiveness or quality before they are sold. The legal status of compounded tirzepatide and semaglutide changed after the shortages ended; those pages cover the rules.

The differences that matter

Evidence. The phase 3 trials (SURMOUNT for tirzepatide, STEP for semaglutide) tested the approved products at labelled doses. A compounded preparation may use a different salt form, concentration or excipients, and no trial has tested it. On this site the branded products carry evidence grade A and compounded injections grade C; see the formulation evidence grades.

Formulation. Approved injectables come in pens or single-dose vials at fixed strengths. Compounded products are multi-dose vials at a concentration chosen by the pharmacy, drawn up with a syringe; some add vitamin B12, B6, glycine, niacinamide or L-carnitine. Additives change the formulation, not the evidence.

Dosing. With pens, the dose is the pen’s strength. With vials, the dose is a volume you draw; the same vial can be used at more than one dose, which is why compounded plans often price by total milligrams and step up as the dose rises.

Regulatory status. The approved product’s status is settled. Compounded copies of approved drugs are permitted only in defined circumstances, and enforcement has changed since the shortages were declared resolved.

Price. Manufacturer direct-to-patient programs sell the approved products for cash at published prices, and several telehealth providers pass those prices through with a plan fee on top. Compounded plans are priced by the provider and vary by pharmacy, formulation and dose.

What the verified numbers show

At our latest verification, the pricing database includes both a brand-name pathway and compounded plans from the same provider, which makes the comparison concrete. Lavender Sky Health lists Wegovy pens at a direct-to-patient price of $499 per month plus a $25 monthly plan fee ($6,288 over twelve months before the consultation fee, which it does not publish), while its lowest compounded tirzepatide plan works out to $104–$130 per month at the starting dose ($1,248–$1,560 over twelve months, also before the consultation fee). Those figures are on the provider profile with their sources and dates, and the brand vs compounded calculator lets you put in your own fees and doses.

How to decide

The choice is clinical as well as financial and belongs with you and a licensed clinician. The questions that decide it are whether insurance or a savings program makes the approved product affordable, whether you want the evidence and quality assurance of an approved product, and, if you choose compounded, whether the provider names the pharmacy, discloses the formulation, and publishes what the price does at higher doses. The questions to ask before you pay cover the last three.

Questions this page answers

Is compounded tirzepatide the same drug as Zepbound?: It contains the same active ingredient, but it is a different product: made by a pharmacy rather than the manufacturer, not reviewed by FDA, sometimes with a different salt form, concentration or added ingredients, and without the trial evidence that supports the approved product.
Why is compounded medication cheaper?: Compounding pharmacies buy the active ingredient and prepare vials without the approved product's development, trial and marketing costs, and without the manufacturer's list price. The lower price comes with the absence of FDA review of the finished product.

Sources

Zepbound (tirzepatide) prescribing information (label)
Wegovy (semaglutide) prescribing information (label)
FDA: Human drug compounding — 503A and 503B (regulator)
Verified brand and compounded plan prices in the pricing database (provider)

Educational information, not medical advice. Decisions about GLP-1 medication belong with you and a licensed clinician who knows your history. Compounded medications are not FDA-approved. Report an error.